UMnyango Wezizwe Zonke

I-CT011 iwumkhiqizo we-GPC3 CAR T-cell ozimele ofanele ukwelashwa kwe-hepatocellular carcinoma (HCC). I-CT011 yathola imvume ye-IND evela kwi-NMPA ngo-2019 yokwelapha iziguli ezine-GPC3-positive solid tumor okwakuyimvume yokuqala ye-IND eShayina yokwelashwa kwe-CAR T-cell ngokumelene ne-solid ...Funda kabanzi»

Uprofesa waseyunivesithi yaseRussia oseminyakeni yakhe yokugcina yama-70 unesifo esithuthukile se-multiple myeloma. Ngemva kokwelashwa kaningi kanye nokufakelwa kabusha kwe-autologous kabili, wafunda ngokwelashwa okuphambili okulwa nomdlavuza i-CAR-T eShayina, ngakho weza eShayina ukuzokwamukela iseli le-CAR-T...Funda kabanzi»

Ngomhlaka-20 kuJulayi, i-New Drug Application (NDA) ye-pCAR-19B eyathuthukiswa ngokuzimela yi-Precision Biology yamukelwa ngokusemthethweni yi-China National Medical Products Administration (NMPA). Lo mkhiqizo uwumkhiqizo wokuqala we-CAR-T we-leukemia yezingane eShayina, osetshenziselwa ukwelapha iziguli ezineminyaka engu-3-21 ...Funda kabanzi»

I-satricabtagene autoleucel (Satri-cel, CT041) iwumkhiqizo we-CAR T-cell owukhethekayo ngokumelene nephrotheni i-Claudin18.2 enamandla okuba phambili emhlabeni jikelele. I-Satri-cel ihlasela amathumba aqinile e-Claudin18.2 ngokugxila kakhulu kumdlavuza wesisu/umdlavuza we-gastroesophageal junction...Funda kabanzi»

NgoSepthemba 6, 2021, i-JW Therapeutics yamemezela ukuthi i-National Medical Products Administration (NMPA) yaseShayina ivumile i-New Drug Application (NDA) yomkhiqizo wayo we-anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy injection (relma-cel) ...Funda kabanzi»

I-Equecabtagene autoleucel (eque-cel), ukwelashwa kwe-T-cell okuqondiswe ku-B-cell maturation-targeting chimeric antigen receptor (CAR) okususelwa kumuntu ngokugcwele, kubonise amandla okwelapha i-repeated noma i-refractory multiple myeloma (R/RMM). Ngomhlaka-30 Juni 2023, i-National Medical Products Admi...Funda kabanzi»

Ngomhlaka-11 Okthoba 2024, i-National Medical Product Administration (NMPA) yaseShayina ivumile isicelo se-Investigational New Drug (IND) se-Inaticabtagene Autoleucel (CNCT19 Injection), ukwelashwa kweseli le-antigen receptor (CAR)-T eliqondiswe ku-CD19, ukwelapha i-Immune thrombocytopenia ...Funda kabanzi»

Ngomhlaka-1 Mashi 2024, i-China National Medical Products Administration (NMPA) yavuma ukwethulwa komkhiqizo weseli ye-CAR-T i-Zevorcabtagene AutoLeucel (Zevor-cel, CT053) yokwelapha iziguli ezindala ezine-myeloma ephindaphindayo noma engaphili kahle esezithuthuke ngemuva kwemigqa emithathu yokwelashwa (...Funda kabanzi»